You Position: Home > Paper
移植物中CD4+CD25+T细胞的表达与异基因造血干细胞移植后移植物抗宿主病的相关性
( views:183, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF ORGAN TRANSPLANTATION
- Issue:
- 6
- DOI:
- 10.3760/cma.j.issn.0254-1785.2007.06.015
- Key Word:
- No keyword available
Abstract： @@ 异基因造血干细胞移植是治疗恶性血液病的有效手段之一,而其并发症移植物抗宿主病(GVHD)严重影响患者的预后和生存质量.近年来已有研究表明,去除移植物中的CD4+CD25+T细胞,移植后aGVHD的发生率上升[1-5].这说明移植物中CD4+CD25+T细胞表达水平与GVHD的发生相关.因此,我们对移植物中CD4+CD25+T细胞亚群比例与受者GVHD的发生进行了初步研究.报告如下.
- [1]Emmanuel, Zorn,Haesook T, Kim,Stephanie J, Lee,etc.Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.[J].2005,106(8).
- [2]Patricia A, Taylor,Christopher J, Lees,Bruce R, Blazar.The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.[J].2002,99(10).
- [3]陆道培主编.白血病治疗学[M].1992.
- [4]Hoffmann P,Strober S,Edinger M,etc.Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.[J].2002,196(3).
- [5]Marta, Stanzani,Sergio L R, Martins,Rima M, Saliba,etc.CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.[J].2004,103(3).
- [6]Trenado A,Klatzmann D,Vasey D,etc.CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.[J].2002,196(3).
- [7]Plottner H,Berchtold S,Dieckmann D,etc.Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.[J].2001,193(11).
- [8]Piotr, Trzonkowski,Jan Maciej, Zaucha,Jolanta, Mysliwska,etc.Differences in kinetics of donor lymphoid cells in response to G-CSF administration may affect the incidence and severity of acute GvHD in respective HLA-identical sibling recipients.[J].2004,21(1).